Derek Burkhard and Mike Ramirez discuss notable big pharma full-year 2019 presentations.

Topics covered in this episode include:

• Overall company performance of Merck, Roche, AstraZeneca, Gilead, Sanofi, and GlaxoSmithKline (1:00)

• Current spin-offs & rationale (20:49)

• Discussion on notable big pharma M&A deals, and companies that may be looking to engage in M&A in the near future (27:49)

• China revenues, growth, and the potential impact of COVID-19 (36:42)

To learn more about Datamonitor Healthcare, Biomedtracker, and other offerings from Pharma Intelligence, visit:

pharmaintelligence.informa.com/

Ver todos los episodios